These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 3085789

  • 1. Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate.
    Gibbs CJ, Aaron JE, Peacock M.
    Br Med J (Clin Res Ed); 1986 May 10; 292(6530):1227-9. PubMed ID: 3085789
    [Abstract] [Full Text] [Related]

  • 2. Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease.
    Boyce BF, Smith L, Fogelman I, Johnston E, Ralston S, Boyle IT.
    Lancet; 1984 Apr 14; 1(8381):821-4. PubMed ID: 6143140
    [Abstract] [Full Text] [Related]

  • 3. Effective short term treatment of Paget's disease with oral etidronate.
    Preston CJ, Yates AJ, Beneton MN, Russell RG, Gray RE, Smith R, Kanis JA.
    Br Med J (Clin Res Ed); 1986 Jan 11; 292(6513):79-80. PubMed ID: 3080099
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease.
    MacGowan JR, Pringle J, Morris VH, Stamp TC.
    Skeletal Radiol; 2000 May 11; 29(5):279-82. PubMed ID: 10883448
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group.
    Miller PD, Brown JP, Siris ES, Hoseyni MS, Axelrod DW, Bekker PJ.
    Am J Med; 1999 May 11; 106(5):513-20. PubMed ID: 10335722
    [Abstract] [Full Text] [Related]

  • 12. The treatment of Paget's bone disease with sodium ethidronate.
    Fromm GA, Schajowicz F, Casco C, Ghiringhelli G, Mautalen CA.
    Am J Med Sci; 1979 May 11; 277(1):29-37. PubMed ID: 106728
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diphosphonates in Paget's disease.
    Russell RG, Smith R, Preston C, Walton RJ, Woods CG.
    Lancet; 1974 May 11; 1(7863):894-8. PubMed ID: 4133419
    [No Abstract] [Full Text] [Related]

  • 15. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
    Altman RD, Johnston CC, Khairi MR, Wellman H, Serafini AN, Sankey RR.
    N Engl J Med; 1973 Dec 27; 289(26):1379-84. PubMed ID: 4201876
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
    Rashid M, Khairi A, Johnston C.
    Clin Orthop Relat Res; 1977 Dec 27; (127):94-105. PubMed ID: 410576
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.